Zogenix reported $849.09M in Market Capitalization for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 2.67B 1.24B
Acura Pharmaceuticals ACUR:US $ 42.96M 35.66M
Adamas Pharmaceuticals ADMS:US 223.88M 15.88M
Aerie Pharmaceuticals AERI:US $ 538.46M 212.3M
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Antares Pharma ATRS:US $ 618.95M 117.01M
Arena Pharmaceuticals ARNA:US $ 3.64B 526.29M
AstraZeneca AZN:LN 138.77B 24.78B
Becton, Dickinson and BDX:US $ 70.6B 755.31M
Biocryst Pharmaceuticals BCRX:US $ 2.57B 239.02M
Biogen BIIB:US $ 42.17B 9.96B
Cardinal Health CAH:US $ 14.03B 2.53B
Esperion Therapeutics ESPR:US $ 340.74M 255.52M
Flexion Therapeutics FLXN:US $ 306.78M 104.24M
GlaxoSmithKline GSK:LN 70.63B 794.04M
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Heron Therapeutics HRTX:US $ 1.09B 490.97M
Intra Cellular Therapies ITCI:US $ 3.03B 286.74M
Johnson & Johnson JNJ:US $ 425145.86M 8679.8M
Marinus Pharmaceuticals MRNS:US $ 418.01M 239.19M
Merk MRK:US $ 190131.55M 6786.63M
Nektar Therapeutics NKTR:US $ 3.3B 172.65M
Neurocrine Biosciences NBIX:US $ 9.08B 123.68M
Pfizer PFE:US $ 241143.67M 21937.97M
Revance Therapeutics RVNC:US $ 2B 126.68M
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Teva Pharmaceutical TEVA:IT 34.99B 801.25M
Zogenix ZGNX:US $ 849.09M 115.36M